| US9439859B2 |
Adjuvant incorporation in immunotherapeutics |
2016-09-13 |
Harvard
College Brigham and Womens Hospital Inc. Massachusetts
Institute of Technology |
(225) |
| US10695306B2 |
Systems and methods for treating vitiligo |
2020-06-30 |
Transdermal Biotechnology
Inc. |
(226) |
| US11369664B2 |
Topical composition
for improved healing of open wounds |
2022-06-28 |
Eleos Pharmaceuticals Inc. |
(227) |
| US20200214961A1 |
Botulinum nanoemulsions |
2020-07-09 |
UMass Lowell |
(228) |
| WO2020102494A1 |
Nanoemulsion compositions
having enhanced permeability |
2020-05-22 |
Bluewillow Biologics, Inc. |
(229) |
| WO2020146415A1 |
Methods of treating cancer |
2020-07-16 |
Foghorn Therapeutics
Inc. |
(230) |
| WO2020150633A1 |
Gene editing
to improve joint function |
2020-07-23 |
Orthobio Therapeutics, Inc. |
(231) |
| WO2020172260A1 |
Topical composition for improved healing
of ocular ailments |
2020-08-27 |
Application filed by BUICE Mona E., SAILORS David M., Woody Jonathan,
James Louis Wood, GREESON Joshua Z. |
(232) |
